Semnan University of Medical Sciences

Research and Technology Vice Chancellor

Kocagöz, Tanil and Ercis, Serpil and Darka, Özge and Hascelik, Gulsen and Salmanzadeh-Ahrabi, Siavosh and Kocagöz, Sesin (2007) Quicolor: A novel system for rapid antibacterial susceptibility testing. Annals of Microbiology. pp. 131-135.

[img] PDF
Download (135Kb)

    Abstract

    Early determination of antibacterial susceptibility increases the success of therapy, decreases unnecessary use of antibacterials Early determination of antibacterial susceptibility increases the success of therapy, decreases unnecessary use of antibacterials and side effects and lowers the overall healthcare costs. We have evaluated a rapid antibacterial susceptibility test, Quicolor and side effects and lowers the overall healthcare costs. We have evaluated a rapid antibacterial susceptibility test, Quicolor (Salubris Inc., Massachusetts, USA), which is based on a rapid culture medium that indicates growth early by changing its (Salubris Inc., Massachusetts, USA), which is based on a rapid culture medium that indicates growth early by changing its colour. Quicolor proved to be a reliable rapid test for determining antibacterial susceptibility, having an overall agreement colour. Quicolor proved to be a reliable rapid test for determining antibacterial susceptibility, having an overall agreement of 97.6% with the conventional CLSI sisk diffusion susceptibility test results. Between two methods overall agreement was of 97.6% with the conventional CLSI sisk diffusion susceptibility test results. Between two methods overall agreement was 96.7% for Enterobacteriaceae, 96.8% for staphylococci and 94.2% for non-fermentative bacteria. There was only 0.6% major discrepancy 96.7% for Enterobacteriaceae, 96.8% for staphylococci and 94.2% for non-fermentative bacteria. There was only 0.6% major discrepancy in Enterobacteriaceae, 1.7% in staphylococci and 0.9% in non-fermentative bacteria. Since the test provides results in 3.5–6 in Enterobacteriaceae, 1.7% in staphylococci and 0.9% in non-fermentative bacteria. Since the test provides results in 3.5–6 h, it can provide the means to choose the right treatment regimen the same day the infectious agent is isolated. h, it can provide the means to choose the right treatment regimen the same day the infectious agent is isolated.

    Item Type: Article
    Subjects: R Medicine > R Medicine (General)
    Divisions: Faculty of Medical Sciences > School of Medicine
    Depositing User: Mr Vahab Moshtaghi
    Date Deposited: 05 Feb 2017 10:11
    Last Modified: 05 Feb 2017 10:11
    URI: http://eprints.semums.ac.ir/id/eprint/811

    Actions (login required)

    View Item